Revenue increased around 200% just in the past year. With biotech, it's all about projecting future value. If revenue increases another 100-200% over the next 12 months, then we could be looking at an even higher market cap and PPS. Stem cell being projected to be a $270 billion industry by 2025, it would seem that the sky really is the limit with this one.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.